《Hepatology International》雜志的最新年發(fā)文量為120篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質量文章，以保持其在胃腸肝病學領域的學術影響力。
該刊聚焦于醫(yī)學-胃腸肝病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發(fā)表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Hepatology International 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- Goals and targets for personalized therapy for HCC39
- Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis28
- Hepatic encephalopathy: a critical current review20
- Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg18
- Precision-cut liver slices: a versatile tool to advance liver research16
- Management of ascites and hepatorenal syndrome16
- The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting15
- Budd-Chiari syndrome/hepatic venous outflow tract obstruction15
- Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis14
- APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation14
國家/地區(qū)發(fā)文量
- CHINA MAINLAND100
- USA56
- India42
- Japan39
- South Korea27
- Taiwan24
- England20
- Italy14
- Egypt12
- GERMANY (FED REP GER)12
